Abstract
Summary
The oral administration of rifampin to cynomolgus monkeys at dosage levels of 40, 80, and 110-120 mg/kg for 180 consecutive days resulted in marked lowering of serum cholesterol levels. Choleretic activity or complexing with bile acids by rifampin may be a mechanism (s) for the observed hypocholesterolemic effect.
Get full access to this article
View all access options for this article.